Clinical Trial Update: Real-World Study of PADN for the Treatment of PAH

View source ↗

Summary

A real-world study evaluating pulmonary artery denervation (PADN) for treating pulmonary arterial hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Pulmonary Artery Denervation (PADN) (Pulmonary Artery Denervation)

Snippet

Sponsor: Pulnovo Medical (Wuxi) Co., Ltd. | Conditions: Pulmonary Hypertension, Hypertension, Pulmonary Arterial | Status: RECRUITING